Recent Quarter Total Invested
$130.69 M
Recent Quarter Institutional Ownership Percentage
86.27%
Total Invested of Last Quarter
$292.88 M
Ownership Percentage of Last Quarter
96.87%
ALX Oncology Holdings Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VENBIO PARTNERS LLC | 11/14/2024 | 9.70 M | $17.65 M | 0.00% | 18.41% |
| TANG CAPITAL MANAGEMENT LLC | 11/14/2024 | 4.20 M | $7.65 M | 100.00% | 7.98% |
| VIVO CAPITAL, LLC | 11/13/2024 | 4.03 M | $7.34 M | -4.40% | 7.66% |
| REDMILE GROUP, LLC | 11/14/2024 | 3.84 M | $6.98 M | -4.95% | 7.28% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 2.60 M | $4.74 M | 100.00% | 4.94% |
| BIOIMPACT CAPITAL LLC | 11/13/2024 | 2.41 M | $4.39 M | 10.50% | 4.57% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 2.00 M | $3.64 M | 51.10% | 3.80% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 700,847 | $1.28 M | 0.06% | 1.33% |
| STATE STREET CORP | 11/14/2024 | 671,376 | $1.22 M | -4.84% | 1.27% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 660,059 | $1.20 M | 125.87% | 1.25% |
| PRIVIUM FUND MANAGEMENT B.V. | 11/01/2024 | 509,059 | $926,487 | 28.24% | 0.97% |
| TWO SIGMA ADVISERS, LP | 11/14/2024 | 500,500 | $910,910 | 640.38% | 0.95% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 457,717 | $833,045 | 80,060.60% | 0.87% |
| ACADIAN ASSET MANAGEMENT LLC | 11/12/2024 | 426,424 | $773,000 | 100.00% | 0.81% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 11/14/2024 | 383,512 | $697,992 | 92.29% | 0.73% |
| MORGAN STANLEY | 11/14/2024 | 320,772 | $583,806 | -52.36% | 0.61% |
| XTX TOPCO LTD | 11/14/2024 | 317,322 | $577,526 | 100.00% | 0.60% |
| D. E. SHAW & CO., INC. | 11/14/2024 | 290,396 | $528,520 | 1,433.24% | 0.55% |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 11/04/2024 | 257,779 | $469,158 | 100.00% | 0.49% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 256,879 | $467,519 | 19.34% | 0.49% |
| WALLEYE CAPITAL LLC | 11/14/2024 | 230,875 | $420,193 | 110.34% | 0.44% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 225,302 | $410,050 | -4.54% | 0.43% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 174,623 | $317,814 | 325.81% | 0.33% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2024 | 167,831 | $305,452 | 15.18% | 0.32% |
| MARSHALL WACE, LLP | 11/14/2024 | 160,059 | $291,308 | -74.82% | 0.30% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 155,300 | $282,646 | -64.56% | 0.29% |
| SQUAREPOINT OPS LLC | 11/14/2024 | 137,983 | $251,129 | 100.00% | 0.26% |
| VERITION FUND MANAGEMENT LLC | 11/14/2024 | 133,025 | $242,106 | 308.42% | 0.25% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 105,894 | $192,727 | 0.00% | 0.20% |
| GRAHAM CAPITAL MANAGEMENT, L.P. | 11/14/2024 | 96,849 | $176,265 | 304.52% | 0.18% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 11/08/2024 | 83,042 | $151,136 | 207.40% | 0.16% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 80,380 | $146,291 | -23.42% | 0.15% |
| KENNEDY CAPITAL MANAGEMENT LLC | 11/14/2024 | 74,679 | $135,916 | -75.72% | 0.14% |
| ALLIANCEBERNSTEIN L.P. | 11/14/2024 | 71,730 | $130,549 | 0.00% | 0.14% |
| CITADEL ADVISORS LLC | 11/14/2024 | 71,600 | $130,312 | 105.75% | 0.14% |
| ABRDN PLC | 10/25/2024 | 66,211 | $120,504 | 0.00% | 0.13% |
| BARCLAYS PLC | 11/19/2024 | 59,502 | $107,000 | 243.60% | 0.11% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 52,100 | $94,822 | -67.92% | 0.10% |
| GSA CAPITAL PARTNERS LLP | 11/05/2024 | 48,204 | $88,000 | 100.00% | 0.09% |
| RHUMBLINE ADVISERS | 11/12/2024 | 42,111 | $76,636 | -23.74% | 0.08% |
| NAN FUNG GROUP HOLDINGS LTD | 11/13/2024 | 41,950 | $76,349 | 0.00% | 0.08% |
| DEKABANK DEUTSCHE GIROZENTRALE | 10/24/2024 | 41,000 | $468,000 | 0.00% | 0.08% |
| JPMORGAN CHASE & CO | 11/08/2024 | 40,934 | $74,501 | 1.26% | 0.08% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 37,646 | $68,806 | 8.98% | 0.07% |
| SHERBROOKE PARK ADVISERS LLC | 11/14/2024 | 34,373 | $62,559 | 55.03% | 0.07% |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 10/24/2024 | 31,710 | $57,712 | 0.93% | 0.06% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 30,348 | $55,233 | 23.56% | 0.06% |
| UBS GROUP AG | 11/14/2024 | 29,240 | $53,217 | 89.22% | 0.06% |
| VANGUARD PERSONALIZED INDEXING MANAGEMENT, LLC | 11/12/2024 | 28,657 | $52,156 | 100.00% | 0.05% |
| AQR CAPITAL MANAGEMENT LLC | 11/14/2024 | 28,506 | $51,881 | 57.67% | 0.05% |
ALX Oncology Holdings Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of ALXO shares?
During the previous two years, 129 institutional investors and hedge funds held shares of ALX Oncology Holdings Inc.. The most heavily invested institutionals were:
venBio Partners LLC: 9.7 M
TANG CAPITAL MANAGEMENT LLC: 4.2 M
Vivo Capital, LLC: 4.03 M
Redmile Group, LLC: 3.84 M
BlackRock Funding, Inc. /DE: 2.6 M
BioImpact Capital LLC: 2.41 M
-
What percentage of ALX Oncology Holdings Inc. stock is owned by institutional investors?
86.27% of ALX Oncology Holdings Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at ALXO ?
Institutional investors have bought a total of 40.57 M shares in the last 24 months. This purchase volume represents approximately $57.61 M in transactions.